Edition:
United Kingdom

Verastem Inc (VSTM.OQ)

VSTM.OQ on NASDAQ Stock Exchange Global Market

8.28USD
17 Aug 2018
Change (% chg)

$-0.10 (-1.19%)
Prev Close
$8.38
Open
$8.37
Day's High
$8.42
Day's Low
$8.05
Volume
302,669
Avg. Vol
447,704
52-wk High
$9.14
52-wk Low
$2.78

Chart for

About

Verastem, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing drugs to improve outcomes for patients with cancer. The Company operates in the segment of developing drugs for the treatment of cancer. The Company's advanced product candidates are VS 6063, VS 4718 and VS 5584. The Company's... (more)

Overall

Beta: 2.23
Market Cap(Mil.): $171.64
Shares Outstanding(Mil.): 36.99
Dividend: --
Yield (%): --

Financials

  VSTM.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.24 -- --
ROI: -65.61 1.78 14.61
ROE: -67.03 3.28 16.33

BRIEF-Verastem Oncology Announces Public Offering Of 7.78 Mln Common Shares Priced At $4.50per Share

* VERASTEM ONCOLOGY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

16 May 2018

BRIEF-Verastem Oncology Announces Public Offering Of Common Stock

* VERASTEM ONCOLOGY ANNOUNCES PUBLIC OFFERING OF COMMON STOCK

15 May 2018

BRIEF-Verastem Oncology Reports Q1 Loss Per Share Of $0.41

* VERASTEM ONCOLOGY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

03 May 2018

BRIEF-Verastem Reports Year-End 2017 Financial Results

* VERASTEM - EXPECTS TO HAVE SUFFICIENT CASH, CASH EQUIVALENTS AND INVESTMENTS TO FUND CURRENT OPERATING PLAN AND CAPEX REQUIREMENTS INTO H2 2018 Source text for Eikon: Further company coverage:

13 Mar 2018

Earnings vs. Estimates